Alison Tree
alison-tree.bsky.social
Alison Tree
@alison-tree.bsky.social
Prostate oncologist
June 27, 2025 at 11:12 AM
Pleasure to be at the MRI in RT symposium at USZ @mguckenberger.bsky.social Meme of the day goes to Luca Boldrini
June 27, 2025 at 11:06 AM
Fantastic opening plenary at #UKOF25 by @charlesswanton.bsky.social Cancer initiation is not a simple matter of DNA damage from carcinogens. Forget everything you learned before!
June 12, 2025 at 1:02 PM
What could be better than 5 days in Verona in October, learning about prostate cancer? Comprehensive multidisciplinary programme aimed at oncologists, urologists, radiologists and anyone else involved in treated prostate cancer. Spread the word!
May 21, 2025 at 4:12 PM
Congratulations to Professor Faivre-Finn on the ESTRO Breur award, and using your platform to encourage us all to address gender inequality in academic radiation oncology 👏 #ESTRO25
May 5, 2025 at 12:39 PM
Congratulations to @montefiored.bsky.social for a great presentation of the ARISTOTLE trial 👏. Always learn a lot from an RCT, sometimes not the things you were expecting to learn #ESTRO2025
May 5, 2025 at 9:07 AM
Significant benefit to focal boost in prostate cancer out to 10 years in FLAME trial #ESTRO2025 Fifteen percent of men avoid further treatment just due to the boost 🏆
May 5, 2025 at 8:52 AM
Great summary from Piet Ost, summarising what we know about systemic therapy +/- SBRT (and vice versa) in prostate oligomets #ESTRO25
May 4, 2025 at 10:46 AM
HYPO-RT-PC 10 year data presented at #ESTRO2025. Seven fractions def non-inferior to 39 fractions, suggestion that 7 fractions might even be more likely to cure?
May 3, 2025 at 1:34 PM
Exciting data presented in ESTRO 2025 plenary: 5 fraction adjuvant breast RT (26 Gy) at least as good (and possibly better?) than 15 fractions @icr.ac.uk #ESTRO2025
May 3, 2025 at 8:42 AM
Whilst a source of tyranny through most of the year, today the office whiteboard is bringing me joy. A new year of possibilities- what shall we do? #radonc #medsky ☢️ #oncsky
January 2, 2025 at 9:44 AM
Pleasure to be in beautiful
Tübingen for the Nikolaus symposium on adaptive radiotherapy. Great to see the updated MOMENTUM recruitment (160,000 MRIs collected!) @mrlconsortium.bsky.social and plans for the MARS trial @cihangani.bsky.social
December 6, 2024 at 11:50 AM
The amazing @drdavidpalma.bsky.social reminding us that leaving mets untreated leads to poorer outcomes. SBRT must be driven by next gen imaging #UKSABRconsortium #medsky #radonc
November 21, 2024 at 5:24 PM
Dr Harshani Green presenting her dosimetric work, testing whether Cyberknife, VMAT or protons are best for a treatment of RCC. Protons may have some dosimetric benefits for OARs @icrlondon.bsky.social #SABRconsortium #medsky
November 21, 2024 at 2:11 PM
Patty Diez showing the incredible amount of work RTTQA have done to accredit nearly all UK centres for SBRT 👏 #medsky #UKSABRconsortium
November 21, 2024 at 12:47 PM
Masterclass from Professor Marcel van Herk @cruk-mi.bsky.social , starting with the famous/notorious (his words!) margin recipe that bears his name #medsky #SABRconsortium
November 21, 2024 at 12:16 PM
As well as possibly being more effective, 26 Gy in one fraction for RCC may preferentially spare normal
kidney tissue, minising effect on GFR #SABRconsortium #medsky #radonc
November 21, 2024 at 11:52 AM
And we are off! Packed house for the 2024 #SABRconsortium, record numbers of delegates and stellar speakers including @drdavidpalma.bsky.social and Shankar Siva (still on the other platform). #medsky @drpeedell.bsky.social @gerryhanna.bsky.social
November 21, 2024 at 11:29 AM
Delighted to see Dr Sian Cooper present the primary endpoint of the HERMES trial at the MR Linac consortium meeting in Singapore today. Toxicity in 2 fractions appears low with MRI-guided adaptive radiotherapy @icrlondon.bsky.social
November 15, 2024 at 1:57 PM